Narvaneni Spandana, Fasulo Sydney M, Kumar Vinod, Singh Balraj, Sultana Yasmeen
Internal Medicine, St. Joseph's Regional Medical Center, Paterson, USA.
Hematology and Oncology, St. Joseph's Regional Medical Center, Paterson, USA.
Cureus. 2021 Jan 19;13(1):e12784. doi: 10.7759/cureus.12784.
Emerging cases of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) have been associated with a variety of disorders including respiratory failure, immune reactive syndrome, multiorgan failure, and hypercoagulable states. COVID-19 induces a severe global inflammatory response which can result in endothelial damage leading to hypercoagulability. Most COVID-19 cases of hypercoagulable states reported venous thrombosis. We report here a case of a 65-year-old Hispanic male diagnosed with bilateral acute lower limb ischemia and renal infarcts secondary to a severe COVID-19 infection.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病（COVID-19）新发病例与多种病症相关，包括呼吸衰竭、免疫反应综合征、多器官功能衰竭和高凝状态。COVID-19引发严重的全身性炎症反应，可导致内皮损伤，进而引起高凝状态。大多数报告的COVID-19高凝状态病例出现静脉血栓形成。我们在此报告一例65岁西班牙裔男性病例，该患者被诊断为双侧急性下肢缺血和严重COVID-19感染继发的肾梗死。
